ConMed Canada Revenue and Competitors
Estimated Revenue & Valuation
- ConMed Canada's estimated annual revenue is currently $989.5M per year.
- ConMed Canada received $275.0M in venture funding in January 2019. 0
- ConMed Canada's total funding is $38M.
- ConMed Canada's current valuation is $4B. (January 2022)
Employee Data
- 00
ConMed Canada's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Executive Assistant to VP Sales | Reveal Email/Phone |
2 | Chief Intellectual Property Counsel | Reveal Email/Phone |
3 | Chief Information Officer | Reveal Email/Phone |
4 | Chief Intellectual Property Counsel | Reveal Email/Phone |
5 | Chief Model Maker | Reveal Email/Phone |
6 | Corporate VP Regulatory Affairs | Reveal Email/Phone |
7 | EVP, Strategy and Corporate Development | Reveal Email/Phone |
8 | VP, Digital, Data and Analytics | Reveal Email/Phone |
9 | VP R&D - Advanced Surgical | Reveal Email/Phone |
10 | VP OEM and Inside Sales | Reveal Email/Phone |
ConMed Canada Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $31.1M | 124 | -4% | N/A | N/A |
#2 | $4M | 16 | -6% | N/A | N/A |
#3 | $78.3M | 312 | 9% | N/A | N/A |
#4 | $23.1M | 92 | 6% | N/A | N/A |
#5 | $9.3M | 37 | 9% | N/A | N/A |
#6 | $75.3M | 240 | 3% | $53.9M | N/A |
#7 | $267.6M | 1066 | 13% | N/A | N/A |
#8 | $36.6M | 0 | N/A | $1.3B | N/A |
#9 | $30.9M | 123 | -20% | N/A | N/A |
#10 | $8.5M | 34 | -17% | N/A | N/A |
What Is ConMed Canada?
CONMED Canada is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. Our products are technological leaders in the specialties that we serve: Orthopaedics, General Surgery, Gynecology, Gastroenterology, Pulmonology, and Anesthesiology. CONMED's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. Our emphasis is on our customer's satisfaction and on our enhanced patient outcomes. We strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. CONMED Canada's is headquartered in Mississauga, Ontario , and employs over 100 people across the country.
keywords:N/A
$38M
Total Funding
N/A
Number of Employees
$989.5M
Revenue (est)
N/A
Employee Growth %
$4B
Valuation
N/A
Accelerator
ConMed Canada News
CONMED Corporation ? Xtant Medical Holdings Inc. ... North America: USA, Canada, and Mexico, etc. Asia-Pacific: China, Japan, Korea, India,...
... Medtronic Plc,CONMED Corporation,Arthrex Inc,Stryker Corporation ... by Countries North America: United States, Canada, and Mexico.
North America (United States, Canada and Mexico); Europe (Germany, France, ... Carefusion; Censis Technologies; Conmed; Getinge...
LARGO, Fla.--(BUSINESS WIRE)--Mar 15, 2021-- CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at ...
Conmed Corporation (NASDAQ: CNMD), an Utica, N.Y.-based medical technology company, acquired SurgiQuest, Inc., a Milford, Connecticut-based developer of an integrated access management technology for use in laparoscopic and robotic procedures, for $265m. The transaction, subject to customary cl ...
Other Companies in Mississauga
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 1 | -80% | N/A |
#2 | $0.1M | 1 | -50% | N/A |
#3 | $0.1M | 1 | -50% | N/A |
#4 | $0.2M | 3 | N/A | N/A |
#5 | $0.2M | 3 | N/A | N/A |
ConMed Canada Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2019-01-24 | $275.0M | Undisclosed | Article |